Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 1
2006 1
2007 1
2011 1
2012 5
2013 1
2014 1
2015 1
2017 1
2019 2
2020 3
2021 1
2022 3
2023 3
2024 5
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

24 results

Results by year

Filters applied: . Clear all
Page 1
Complications of Macular Peeling.
Asencio-Duran M, Manzano-Muñoz B, Vallejo-García JL, García-Martínez J. Asencio-Duran M, et al. J Ophthalmol. 2015;2015:467814. doi: 10.1155/2015/467814. Epub 2015 Sep 3. J Ophthalmol. 2015. PMID: 26425351 Free PMC article. Review.
Ocular side effects of oncological therapies: Review.
Asencio-Durán M, Fernández-Gutiérrez E, Larrañaga-Cores M, Klein-Burgos C, Dabad-Moreno JV, Capote-Díez M. Asencio-Durán M, et al. Arch Soc Esp Oftalmol (Engl Ed). 2024 Mar;99(3):109-132. doi: 10.1016/j.oftale.2023.11.003. Epub 2023 Nov 9. Arch Soc Esp Oftalmol (Engl Ed). 2024. PMID: 37949110 Review.
Macular Neovascularization Type Influence on Anti-VEGF Intravitreal Therapy Outcomes in Age-Related Macular Degeneration.
Izquierdo-Serra J, Martin-Pinardel R, Moll-Udina A, Bernal-Morales C, Garay-Aramburu G, Sanchez-Monroy J, Arruabarrena C, Fernandez-Hortelano A, Figueroa MS, Abraldes M, Lavid de Los Mozos FJ, Zapata MA, Ruiz-Moreno JM, Broc-Iturralde L, Gonzalez-Guijarro J, Escobar-Barranco JJ, Gallego-Pinazo R, Parrado-Carrillo A, Dotti-Boada M, Alforja S, Figueras-Roca M, Barthelmes D, Gillies MC, Casaroli-Marano RP, Zarranz-Ventura J; Writing Committee of the Fight Retinal Blindness Spain (FRB! Spain) Users Group. Izquierdo-Serra J, et al. Ophthalmol Retina. 2024 Apr;8(4):350-359. doi: 10.1016/j.oret.2023.10.022. Epub 2023 Nov 2. Ophthalmol Retina. 2024. PMID: 37924946
Role of inflammation in endophthalmitis.
Vallejo-Garcia JL, Asencio-Duran M, Pastora-Salvador N, Vinciguerra P, Romano MR. Vallejo-Garcia JL, et al. Among authors: asencio duran m. Mediators Inflamm. 2012;2012:196094. doi: 10.1155/2012/196094. Epub 2012 Sep 2. Mediators Inflamm. 2012. PMID: 22973073 Free PMC article. Review.
Vitreous diagnosis in neoplastic diseases.
Asencio-Duran M, Vallejo-Garcia JL, Pastora-Salvador N, Fonseca-Sandomingo A, Romano MR. Asencio-Duran M, et al. Mediators Inflamm. 2012;2012:930704. doi: 10.1155/2012/930704. Epub 2012 Sep 26. Mediators Inflamm. 2012. PMID: 23055575 Free PMC article. Review.
Three-Year Outcomes of VEGF Inhibitors in Naive Branch Retinal Vein Occlusion: Fight Retinal Blindness!
Alforja S, Hunt A, Nguyen V, O'Toole L, Gabrielle PH, Invernizzi A, Mehta H, Ponsioen TL, Squirrell D, Casaroli-Marano RP, Barthelmes D, Gillies MC, Zarranz-Ventura J; Fight Retinal Blindness (FRB) users group. Alforja S, et al. Ophthalmol Retina. 2024 Oct;8(10):962-970. doi: 10.1016/j.oret.2024.04.014. Epub 2024 Apr 18. Ophthalmol Retina. 2024. PMID: 38641007
One-Year Anti-VEGF Therapy Outcomes in Diabetic Macular Edema Based on Treatment Intensity: Data from the Fight Retinal Blindness! Registry.
Mehta H, Gabrielle PH, Hashimoto Y, Kibret GD, Arnold J, Guillaumie T, Kheir WJ, Kok G, Vujosevic S, O'Toole L, Mangelschots E, Jaross N, Ceklic L, Daien V, Viola F, Squirrell D, Lavid FJ, Creuzot-Garcher C, Barthelmes D, Gillies M; Fight Retinal Blindness! Study Group. Mehta H, et al. Ophthalmol Retina. 2024 Sep;8(9):872-879. doi: 10.1016/j.oret.2024.04.008. Epub 2024 Apr 16. Ophthalmol Retina. 2024. PMID: 38615818 Free article.
Safety of 6000 intravitreal dexamethasone implants.
Rajesh B, Zarranz-Ventura J, Fung AT, Busch C, Sahoo NK, Rodriguez-Valdes PJ, Sarao V, Mishra SK, Saatci AO, Udaondo Mirete P, Querques G, Farah ME, Lanzetta P, Arevalo JF, Kodjikian L, Chhablani J; for International Ozurdex Study Group. Rajesh B, et al. Br J Ophthalmol. 2020 Jan;104(1):39-46. doi: 10.1136/bjophthalmol-2019-313991. Epub 2019 Apr 30. Br J Ophthalmol. 2020. PMID: 31040132
Incidence, Risk Factors, and Outcomes of Rhegmatogenous Retinal Detachment after Intravitreal Injections of Anti-VEGF for Retinal Diseases: Data from the Fight Retinal Blindness! Registry.
Gabrielle PH, Nguyen V, Arnould L, Viola F, Zarranz-Ventura J, Barthelmes D, Creuzot-Garcher C, Gillies M; Fight Retinal Blindness! Study Group. Gabrielle PH, et al. Ophthalmol Retina. 2022 Nov;6(11):1044-1053. doi: 10.1016/j.oret.2022.05.008. Epub 2022 May 16. Ophthalmol Retina. 2022. PMID: 35589075 Free article.
Pseudomelanoma diagnosis in a tertiary ophthalmologic centre in Spain.
Roca-Cabau MA, Kumaran N, Asencio-Durán M, Pita-Ortiz I, Dabad Moreno JV. Roca-Cabau MA, et al. Among authors: asencio duran m. Can J Ophthalmol. 2024 Dec;59(6):e763-e767. doi: 10.1016/j.jcjo.2024.01.017. Epub 2024 Feb 20. Can J Ophthalmol. 2024. PMID: 38387859
24 results